Bioisosteric Replacement

Bioisosteric Replacement is a medicinal chemistry strategy in which an atom, ion, or group of atoms in a lead compound is systematically substituted with a bioisostere that preserves the essential steric and electronic characteristics of the original moiety while modulating physicochemical, pharmacokinetic, and safety properties so as to maintain or improve the compound’s biological activity.

135

Publications

6.5K

Citations

831

Authors

210

Institutions

Publications per year

2017–2026

42

Authors

831

  1. PE
    Peter Ertl

    Novartis (Switzerland), Switzerland

    4 publications · 325 citations

    4

    h-index

  2. NB
    Nathan Brown

    Institute of Cancer Research, United Kingdom

    3 publications · 348 citations

    3

    h-index

  3. ZY
    Zilya Yamaleeva

    A.E. Arbuzov Institute of Organic and Physical Chemistry, Russia

    2 publications · 35 citations

    2

    h-index

  4. KV
    Konstantin V. Balakin

    Kazan Federal University, Russia

    2 publications · 35 citations

    2

    h-index

  5. TA
    Thomas A. Hunt

    AstraZeneca (United Kingdom), United Kingdom

    2 publications · 46 citations

    2

    h-index

1–5 of 831

Venues

  1. Journal of Medicinal Chemistry

    24 publications · 2K citations

    18

    h-index

  2. Bioorganic & Medicinal Chemistry Letters

    20 publications · 441 citations

    15

    h-index

  3. Bioorganic & Medicinal Chemistry

    10 publications · 429 citations

    10

    h-index

  4. European Journal of Medicinal Chemistry

    9 publications · 308 citations

    9

    h-index

  5. ACS Medicinal Chemistry Letters

    6 publications · 470 citations

    6

    h-index

1–5